Analyst Ratings for Regeneron Pharma (REGN)
REGN Rating Summary
REGN Price Target Summary
- Highest: $1,057.00 (Canaccord)
- Lowest: $152.00 (Jefferies)
- Average: $797.81
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$797.81 (+5%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 69%
Rating Score: 6.5 / 10
Percentile Rank: 69%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | Barclays | Eliana Merle | New Coverage | Overweight (N/A) |
923.00 (N/A) |
787.50 (759.86) |
-3.51% | Details |
| 1/7/2026 | BofA Securities » Updated 1/26/2026 |
Tim Anderson | Upgrade | Buy (Underperform) |
860.00 (N/A) |
776.54 (759.86) |
-2.15% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
